Aptar Digital Well being
Aptar Digital Health is a worldwide knowledgeable in Software program as a Medical Gadget (SaMD), digital Affected person Assist Applications (PSPs) and illness administration options, at the moment introduced a brand new collaboration with Gerresheimer, an modern programs and options supplier and international companion to the pharma, biotech and cosmetics industries, to develop a tailor-made resolution to assist sufferers and well being care professionals in most cancers remedy administration.
By connecting Aptar Digital Well being’s proprietary SaMD platform with Gx SensAir, Gerresheimer’s on-body gadget for the subcutaneous supply of huge biologics molecules, this built-in resolution is meant to enhance total remedy adherence and medical outcomes. Extra particularly, it goals to make distant affected person monitoring simpler, and facilitate the onboarding of sufferers to new therapies, serving to them to higher handle hostile results.
Enhance Affected person Expertise
Each corporations imagine that affected person expertise in oncology may be improved with modern subcutaneous injection units and digital platforms. For pharmaceutical corporations, this collaboration is a chance to supply a extra patient-centric resolution, and deal with potential challenges, akin to remedy interruptions or discontinuations associated to administration points or hostile results. This resolution may also assist the transition from intravenous to subcutaneous administration of oncology medicine.
“We’re honored to collaborate with Gerresheimer, a worldwide industrial companion in drug supply units,” said Sai Shankar, President of Aptar Digital Well being. “By combining our collective and proprietary experience in gadget and software program engineering, we imagine this collaboration has the potential to ship modern options for sufferers, healthcare suppliers and the healthcare {industry}.”
“Combining our efforts opens up new thrilling prospects for optimizing the respective drug remedy and bettering the standard of life for most cancers sufferers,” stated Daniel Diezi, Vice President Digitalization & New Enterprise Fashions at Gerresheimer. “This collaboration in oncology will lay the groundwork for Aptar Digital Well being and Gerresheimer to probably develop into different therapeutic areas sooner or later.”
Designed for Focused Anti-cancer Therapies
This built-in resolution will first be designed for focused anti-cancer therapies akin to PD-1/PDL-1, CTLA-4, with the potential to develop to all therapies delivered subcutaneously.
About Aptar Digital Well being
Aptar Pharma’s Digital Well being division is a part of AptarGroup, Inc., a worldwide chief in drug and shopper product dosing, dishing out and safety applied sciences. Aptar Digital Well being creates end-to-end options to reinforce affected person experiences daily, leveraging a holistic ecosystem of digital interventions. Amplified by an industry-leading portfolio of merchandise and options, Aptar Digital Well being’s providing combines cell and net apps, linked drug supply programs, onboarding, coaching and superior knowledge analytics providers to actively empower sufferers and create a constructive remedy journey. Aptar is headquartered in Crystal Lake, Illinois and has 13,500 devoted workers in 20 international locations. For extra data, please go to www.aptardigitalhealth.com and www.aptar.com.
Trending Merchandise
